Low introductory pricing can make an online GLP-1 program look straightforward. With Wellorithm, however, the most important number is not the first one shown during enrollment—it is the recurring cost that follows it.
Wellorithm is a telehealth facilitator offering compounded semaglutide and tirzepatide as both injections and oral dissolving tablets. Its current website also lists FDA-approved Wegovy and Zepbound as well as Ozempic and Mounjaro. Wellorithm itself does not practice medicine; its terms say independent licensed healthcare professionals make medical decisions through unspecified “Professional Entities.”
Our Wellorithm review found useful treatment-format choice, broad advertised coverage and a comparatively detailed results-guarantee policy. It also found several transparency issues that deserve attention before payment: introductory and recurring prices differ, prescriptions are billed every 28 days, the pharmacy is not publicly identified, state-coverage statements conflict and the website provides inconsistent contact information.
Key takeaways
- Wellorithm offers compounded semaglutide and tirzepatide as both injections and oral dissolving tablets. Its homepage correctly states that these compounded products have not been reviewed or approved by the FDA.
- Recent August 2026 captures of Wellorithm’s enrollment pricing show compounded semaglutide at $147 for the introductory period before a $247 recurring rate, and tirzepatide at $249 before a $349 recurring rate. These figures are not clearly disclosed on Wellorithm’s static public pricing content, so checkout should be treated as the controlling source.
- Wellorithm’s terms say the program operates on a cash-pay basis, does not accept insurance and bills membership fees every 28 days, not once per calendar month. Processed payments are nonrefundable.
- The company does not publicly identify the pharmacy that prepares its compounded GLP-1 prescriptions or clearly name the “Professional Entities” supplying clinical care.
- State availability is contradictory: Wellorithm’s FAQ says it operates in 49 states and excludes Louisiana, while its terms say services are available in all 50 states plus Washington, D.C.
- Wellorithm offers a conditional guarantee that may refund up to four months of fees if an eligible new patient fails to lose at least 10% of baseline body weight after 16 weeks while meeting specified adherence and verification requirements.
Wellorithm at a glance
| Category | What we found |
|---|---|
| Care model | Online intake, licensed-provider evaluation and home delivery |
| Main treatments | Compounded semaglutide and tirzepatide; selected brand-name medications |
| Compounded formats | Injection and oral dissolving tablet |
| Introductory pricing observed | $147 semaglutide; $249 tirzepatide |
| Ongoing pricing observed | About $247 semaglutide; $349 tirzepatide |
| Billing cadence | Every 28 days |
| Insurance | Not accepted under current terms |
| Customer support | 24/7 phone support advertised |
| Pharmacy disclosure | Pharmacy not publicly named |
| State coverage | Public sources conflict |
| Main limitation | Material inconsistencies in public program information |
Information reviewed August 20, 2026. Prices, promotions, pharmacies, medication availability and terms can change.
How does Wellorithm work?
Enrollment starts with an online questionnaire. The current intake asks about height, weight, goal weight, date of birth, medical conditions, current prescriptions, blood pressure, heart rate and several contraindication-related health issues.
Wellorithm’s terms describe the company as a facilitator rather than a medical practice. Licensed providers associated with separate “Professional Entities” are responsible for evaluation, diagnosis and prescribing decisions. Completing the assessment and paying does not mean a GLP-1 prescription is medically appropriate or guaranteed.
The company advertises video consultations, personalized treatment plans and ongoing guidance, although its public materials do not clearly explain how often routine clinical follow-ups occur or whether every patient has a synchronous video visit. Customer-service support is advertised as available around the clock.
If medication is prescribed, Wellorithm’s terms say the program can include consultations, prescriptions and recurring shipments of compounded medication. The identity of the dispensing pharmacy is not specified in those terms.
Which weight-loss medications does Wellorithm offer?
Wellorithm’s homepage currently lists:
- Compounded semaglutide injection
- Compounded tirzepatide injection
- Compounded semaglutide oral dissolving tablets
- Compounded tirzepatide oral dissolving tablets
- Wegovy
- Zepbound
- Ozempic
- Mounjaro
The regulatory distinction matters.
Wegovy and Zepbound are FDA-approved prescription products with weight-management indications. By contrast, Ozempic and Mounjaro are FDA approved for type 2 diabetes rather than weight management; clinicians sometimes prescribe medications off label when medically appropriate, but that is a separate clinical decision.
Compounded products are not FDA-approved generics
Wellorithm correctly discloses that its compounded formulations are not FDA approved. The FDA does not review an individual compounded preparation for safety, effectiveness or quality before it reaches the patient. The agency recommends using compounded GLP-1 medication only when a patient’s medical needs cannot be met by an available FDA-approved drug.
That distinction becomes especially important with Wellorithm’s dissolving tablets. These are independently compounded formulations, not FDA-approved Wegovy tablets, and evidence for an approved semaglutide product should not automatically be assumed to establish the performance of a different compounded dosage form.
How much does Wellorithm cost?
Pricing is one of the more confusing parts of the program.
Wellorithm’s regular homepage does not publish specific treatment prices and its FAQ simply says pricing varies according to the plan and services selected.
However, recent independent captures of Wellorithm’s own checkout catalog reported:
| Treatment | Introductory price | Reported recurring price |
| Compounded semaglutide, injection or ODT | $147 | $247 |
| Compounded tirzepatide, injection or ODT | $249 | $349 |
A three-month semaglutide option has also been recorded at $645, or about $215 per treatment month, while a three-month tirzepatide option was $947, or approximately $316 per month.
Because these rates sit within the enrollment funnel rather than a stable public pricing page, they should be rechecked immediately before publication and again by the consumer before payment.
“Monthly” billing actually occurs every 28 days
Wellorithm’s legal terms add another important detail: membership fees are billed every 28 days.
A 28-day renewal produces approximately 13 billing cycles over 364 days, rather than 12 conventional monthly payments. At a $247 recurring semaglutide rate, for example, 13 equivalent charges would total about $3,211 before any separate shipping, tax or other applicable costs.
Consumers should therefore compare annualized cost, not simply multiply the displayed rate by 12.
Wellorithm’s terms also say listed product prices exclude shipping and taxes, even though some promotional materials elsewhere describe expedited shipping as included. Confirm the final checkout total rather than assuming delivery is always free.
Insurance, labs and continuing support
The homepage suggests that insurance coverage depends on the patient’s plan and says programs may help people understand benefits. Wellorithm’s legal terms are considerably clearer: the weight-loss program operates on a cash basis and insurance is not accepted.
For budgeting purposes, the legal terms are the safer standard unless the company provides written confirmation of a different arrangement for a specific brand-name prescription.
We did not find a clear statement that routine laboratory testing is universally required or included. Patients should ask whether their clinician expects baseline or follow-up bloodwork and whether any laboratory charge sits outside the advertised medication price.
Pharmacy and clinical transparency need improvement
Wellorithm’s lack of pharmacy-specific information is one of the more important weaknesses in this review.
The FDA specifically recommends that consumers receiving compounded GLP-1 medication obtain it from a state-licensed pharmacy. It has also documented fraudulent products carrying nonexistent pharmacy names or labels that falsely named legitimate pharmacies.
Wellorithm’s current website and terms do not publicly identify the pharmacy responsible for its compounded semaglutide or tirzepatide. Its privacy policy refers generally to pharmacies as third parties, but does not name them.
Patients should request the pharmacy’s full legal name, address and state license before using the medication.
Clinical transparency could also be stronger. Wellorithm says it connects users with “Professional Entities,” but its terms do not identify those entities by legal name. Its homepage says patients have access to board-certified obesity specialists, yet the public specialist section lists people under specialties including cardiac surgery, pediatrics and gynecology rather than clearly identifying the clinicians who actually evaluate weight-loss patients.
This does not establish that the underlying clinical service is improper. It does mean patients should verify the name and license of the clinician responsible for their treatment rather than relying on the marketing-page roster.
Public information is internally inconsistent
CliniqGuide found several discrepancies that reduce confidence in the website as a source of precise program information.
The most consequential is geographic coverage. Wellorithm’s current FAQ says it serves 49 states and excludes Louisiana. Its terms instead state that services are available throughout all 50 states plus Washington, D.C.
Contact information also conflicts. Several pages display an address written as “785 15h Street, Office 478 Berlin, De 81566,” while the contact page separately gives 7931 NW 68th Street, Miami, FL 33166.
These inconsistencies do not by themselves determine the quality of medical care, but they are reasonable consumer-protection concerns. A healthcare platform handling prescriptions and sensitive health information should make its legal location, clinical partners and service area easy to verify.
What does the Wellorithm weight-loss guarantee cover?
Wellorithm has one of the more detailed results-guarantee policies we found.
Its terms say an eligible new patient who does not lose at least 10% of baseline body weight after 16 weeks may qualify for reimbursement of up to four months of fees. Requirements include following the prescribed medication regimen for the full 16 weeks and not having used another weight-loss medication during the previous year.
Verification may involve either a clinician’s attestation or a recorded weigh-in using a calibrated scale and a verification code. Refunds are limited to fees actually paid and are processed after review.
This is therefore a conditional financial guarantee—not evidence that every patient should expect to lose 10% of body weight.
Cancellation and refunds
Wellorithm’s terms say patients may cancel by email at any time. Cancellation prevents future cycles, but payments already processed are nonrefundable.
Because billing occurs every 28 days, consumers should save the exact next-renewal date rather than assuming the charge will occur on the same calendar date each month.
The terms do not provide a broad cooling-off refund after payment. Anyone uncertain about treatment should clarify when clinician review, prescription processing and pharmacy fulfillment begin before completing checkout.
Potential benefits
Wellorithm may appeal because it offers:
- Both semaglutide and tirzepatide
- Injectable and needle-free compounded formats
- Selected FDA-approved brand-name options
- Licensed-provider evaluation
- Broad advertised geographic coverage
- 24/7 customer-support availability
- A published, criteria-based weight-loss guarantee
- Cancellation of future renewals without a stated annual commitment
Meaningful limitations
The more important tradeoffs are:
- Compounded products are not FDA approved
- The introductory price is lower than the ongoing rate
- Billing occurs every 28 days rather than monthly
- Processed payments are nonrefundable
- The compounding pharmacy is not publicly named
- The medical “Professional Entities” are not clearly identified
- State-availability statements conflict
- Public contact addresses conflict
- Laboratory costs are unclear
- Oral compounded formulations have not undergone the FDA approval process
- Federal restrictions on routine GLP-1 compounding have tightened since shortages resolved
Safety and eligibility considerations
FDA-approved semaglutide and tirzepatide products commonly cause gastrointestinal effects including nausea, diarrhea, vomiting, constipation and abdominal discomfort. Label warnings also address pancreatitis, gallbladder disease, acute kidney injury related to dehydration, severe gastrointestinal reactions and hypersensitivity.
Wegovy and Zepbound also carry boxed warnings concerning thyroid C-cell tumors observed in animals and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Pregnancy and concurrent medication use require individualized clinical review.
Compounded injections create additional practical concerns because concentrations, vial sizes and syringe markings can differ. The FDA has received reports of compounded-semiglutide overdoses caused by measurement errors, including cases involving five to 20 times the intended dose and some requiring hospitalization.
The FDA also reported, as of May 31, 2026, 990 adverse-event reports associated with compounded semaglutide and more than 730 involving compounded tirzepatide. The agency cautions that an adverse-event report does not prove the medication caused the event.
Who may find Wellorithm worth considering?
Wellorithm may appeal to adults who expect to pay cash, want a choice between semaglutide and tirzepatide and particularly value a needle-free compounded option.
It could also interest consumers who prefer a flexible recurring arrangement rather than paying for an entire year upfront.
It may not suit people who want only FDA-approved weight-loss medication, require insurance authorization, expect a publicly identified pharmacy and medical group before checkout, or prioritize highly transparent program documentation.
Questions to ask before enrolling
- Is the price shown today introductory or recurring?
- What exactly will I pay every 28 days?
- Are shipping, taxes and consultation charges included?
- Which legal medical practice employs or contracts my prescriber?
- What is my clinician’s full name and state license?
- Which pharmacy will compound and dispense my prescription?
- Why is compounded treatment medically appropriate for me?
- Which formulation and concentration will I receive?
- Are laboratory tests required or charged separately?
- Is my state currently supported?
- What date will my next charge occur?
- What documentation is required for the 16-week guarantee?
Final assessment
Wellorithm has several attractive features. It offers two major GLP-1 ingredients, injectable and dissolving-tablet compounded formats, access to selected branded drugs and round-the-clock customer support. Its conditional 16-week refund policy is also more specific than the vague satisfaction guarantees used by some competitors.
The weakness is the amount of verification the consumer must perform independently. The static website does not make recurring GLP-1 prices easy to understand, billing runs every 28 days, the pharmacy and clinical entities are not named, and official pages disagree about state availability and even contact addresses.
For those reasons, Wellorithm may be worth considering only after receiving the important details in writing: the ongoing—not introductory—price, exact formulation, dispensing pharmacy, prescribing clinician, state eligibility and next billing date.
A low first payment should not substitute for those basic trust signals.
Frequently asked questions
Is Wellorithm legitimate?
Wellorithm operates an active telehealth platform with published legal terms, an intake system, customer-support information and a stated model connecting users with licensed healthcare professionals. However, its public disclosures leave important details unresolved, including the identity of its clinical entities and compounding pharmacy. Several pages also conflict on state coverage and company address.
How much does Wellorithm cost?
Recent August 2026 checkout captures show compounded semaglutide at approximately $147 initially and $247 on the recurring plan, while tirzepatide is approximately $249 initially and $349 thereafter. Wellorithm’s general public website does not clearly publish these ongoing figures, so the live checkout should be verified before payment.
Is Wellorithm billed monthly?
Not exactly. Its terms say membership fees renew every 28 days. That can produce 13 charges across roughly one year, rather than 12 calendar-month charges.
Does Wellorithm accept insurance?
Its legal terms state that the weight-loss program operates on a cash basis and insurance is not accepted. The homepage contains more general language suggesting that coverage depends on the plan, so consumers seeking brand-name coverage should obtain written confirmation before enrolling.
Are Wellorithm’s compounded medications FDA approved?
No. Wellorithm explicitly states that its compounded medications have not been FDA approved or reviewed for safety, effectiveness or quality. The FDA recommends compounded GLP-1 medications only when a patient’s medical needs cannot be met by an approved product.
Which pharmacy does Wellorithm use?
Wellorithm does not publicly name the compounding pharmacy in the main website, terms or privacy materials we reviewed. Patients should obtain the pharmacy’s legal name and state license before using a compounded medication.
Is Wellorithm available in every state?
The answer is unclear from Wellorithm’s own website. Its FAQ says 49 states, excluding Louisiana, while its current terms say all 50 states plus Washington, D.C. Verify eligibility directly before payment.
Can I cancel Wellorithm?
Yes. Its terms allow cancellation by email, but payments that have already processed are nonrefundable. Because the program bills every 28 days, check the exact renewal date rather than assuming it occurs monthly.
